Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Giant cell arteritis.

Stuart M Levine1, David B Hellmann

  • 1Division of Molecular and Clinical Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.

Current Opinion in Rheumatology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The radiologist and data: Do we add value or is data just data?

Clinical imaging·2025
Same author

HYDROXYCHLOROQUINE CAN BE RESUMED WITH CLOSE MONITORING AFTER RETINOPATHY HAS DEVELOPED, WITHOUT MAJOR VISUAL LOSS: CASE REPORT.

Retinal cases & brief reports·2023
Same author

Reply.

Journal of the American College of Radiology : JACR·2023
Same author

Personomics: A Progress Report.

The American journal of medicine·2023
Same author

Primrose Journey.

The American journal of medicine·2022
Same author

Renegades, Rebels, and Revolutionaries: Making Medicine a Better Public Trust.

Journal of the American College of Radiology : JACR·2022
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Giant cell arteritis (GCA) affects older adults, causing symptoms like headache and vision loss. Early prednisone treatment is crucial to prevent blindness, though research on methotrexate

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is the most common systemic vasculitis in adults over 50.
  • It primarily affects large and medium arteries, with classic symptoms including headache, jaw claudication, polymyalgia rheumatica (PMR), and visual disturbances.
  • A significant proportion (40%) of patients exhibit occult manifestations, complicating early diagnosis.

Purpose of the Study:

  • To summarize the key aspects of Giant Cell Arteritis, including its clinical presentation, pathogenesis, diagnostic methods, and treatment outcomes.
  • To highlight the importance of early diagnosis and treatment in preventing severe complications such as blindness.
  • To discuss the current understanding of GCA pathogenesis and its association with other vascular conditions like thoracic aortic aneurysms.

Related Experiment Videos

Main Methods:

  • Review of existing literature on Giant Cell Arteritis.
  • Analysis of clinical manifestations, diagnostic criteria, and treatment strategies.
  • Inclusion of findings from recent clinical trials regarding treatment efficacy.

Main Results:

  • GCA presents with diverse symptoms, with many cases having non-classic, occult manifestations.
  • Early diagnosis and treatment with prednisone are vital to avert blindness, the most feared complication.
  • The pathogenesis involves T-cell responses and cytokine variations, and GCA increases the risk of thoracic aortic aneurysms.
  • Advanced imaging techniques provide insights but temporal artery biopsy remains the gold standard for diagnosis.

Conclusions:

  • Giant cell arteritis requires prompt diagnosis and treatment, primarily with prednisone, to prevent vision loss.
  • The disease's pathogenesis is complex, involving immune responses and potentially leading to serious vascular complications.
  • Conflicting results from recent trials necessitate further research into optimal treatment regimens, such as the combination of methotrexate and prednisone.